InDex Pharmaceuticals enrols first patient in the PK study with cobitolimod
InDex Pharmaceuticals Holding AB (publ) today announced that the first patient has been enrolled in the clinical pharmacokinetic study (PK study) with cobitolimod. The purpose […]